| View |
|
DR-XY19470
|
Cefalexin (As Monohydrate)
|
Lorecep
|
500 mg
|
Capsule
|
Prescription Drug (RX)
|
Blister Pack x 10's (Box of 100's)
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Philippine Home PharmaceuticalsI
|
|
|
-
|
09 January 2020
|
06 January 2025
|
| View |
|
DR-XY19474
|
Paracetamol
|
Febrinil
|
150mg/mL
|
Solution For Injection (Im/Iv)
|
Prescription Drug (RX)
|
Amber USP Type I Glass Ampoule x 2mL (10 ampoules placed in a clear plastic tray); Box of 10's
|
Analgesic/Antipyretic
|
Oboi Laboratories
|
India
|
|
Phil Pharmawealth, Inc.
|
Phil Pharmawealth, Inc.
|
Renewal
|
07 April 2024
|
09 August 2029
|
| View |
|
DR-XY19474-G
|
Paracetamol
|
Unbranded
|
150mg/mL
|
Solution For Injection (Im/Iv)
|
Prescription Drug (RX)
|
Amber USP Type I Glass Ampoule x 2mL (10 ampoules placed in a clear plastic tray); Box of 10's
|
Analgesic/Antipyretic
|
Oboi Laboratories
|
India
|
|
Phil Pharmawealth, Inc.
|
Phil Pharmawealth, Inc.
|
Renewal
|
07 April 2024
|
03 August 2029
|
| View |
|
DR-XY19482-B
|
Mefenamic Acid
|
Icelax
|
500mg
|
Capsule
|
Prescription Drug (Rx)
|
Transparent Red PVC Blister Pack x 10's (Box of 100's)
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Basic Pharmaceutical Corporation
|
|
|
Renewal
|
25 May 2022
|
17 January 2027
|
| View |
|
DR-XY19513
|
Mesalazine
|
Salofalk
|
250mg
|
Rectal Suppository
|
Prescription Drug (RX)
|
PVC Blister Pack x 5's (Box of 30's)
|
-
|
Vifor AG Zweigniederlassung Medichemie
|
Switzerland
|
|
A. Menarini Philippines, Inc
|
|
-
|
27 December 2019
|
15 October 2024
|
| View |
|
DR-XY19523
|
Cefalexin (as Monohydrate)
|
Lorecep
|
250mg/ 5mL
|
Powder for Suspension
|
Prescription Drug (Rx)
|
Amber Glass Bottle x 60 mL (Box of 1's)
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Philippine Home Pharmaceuticals
|
|
|
Automatic Renewal
|
20 October 2021
|
22 December 2026
|
| View |
|
DR-XY19524-B
|
Ranitidine Hydrochloride
|
Ulcerix
|
25mg/mL
|
Solution for Injection (I.M. /I.V.)
|
Prescription Drug (RX)
|
USP Type 1 amber glass ampoule x 2mL (Box of 10's)
|
H2 Receptor Antagonist
|
Oboi Laboratories
|
India
|
|
Phil Pharmawealth, Inc.
|
Phil Pharmawealth, Inc.
|
Renewal
|
04 August 2024
|
23 January 2030
|
| View |
|
DR-XY19555
|
Amoxicillin (As Trihydrate)
|
ELEOMOX
|
100 mg/mL
|
Powder For Suspension (Oral Drops)
|
Prescription Drug (RX)
|
Amber glass bottle x 10 mL (Box of l's)
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Vamsler Phils. Incorporated
|
|
|
Automatic Renewal
|
23 December 2021
|
01 February 2027
|
| View |
|
DR-XY19608
|
Cefalexin (As Monohydrate)
|
Airex
|
100mg/mL
|
Powder For Suspension (Oral Drops)
|
Prescription Drug (RX)
|
Amber Bottle x 10 mL
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Medhaus Pharma, Incorporated
|
|
|
Automatic Renewal
|
13 January 2022
|
12 February 2027
|
| View |
|
DR-XY19610
|
Multivitamins
|
Neo-Vita
|
4000 IU,10mg,5mg,15mg,30mcg,400mg,400 IU,10mg,500mcg,20mg
|
Capsule
|
Over-The-Counter (OTC)
|
Foil Strip x 10's (Box of 100's)
|
-
|
Drugmakers Laboratories, Inc.
|
Philippines
|
|
|
|
-
|
05 December 2019
|
16 February 2025
|
| View |
|
DR-XY19711
|
Mometasone Furoate
|
Elica
|
1 mg/g (0.1%)
|
Lotion
|
Prescription Drug (RX)
|
HDPE bottle x 30 mL (Box of 1's)
|
Anti-inflammatory / Antipruritic
|
Famar Montreal Inc.
|
Canada
|
|
Bayer Philippines, Inc.
|
|
Renewal
|
16 August 2024
|
26 October 2029
|
| View |
|
DR-XY19745
|
Magnesium Sulfate
|
None
|
250mg/Ml (25%)
|
Solution For Injection (IM/IV)
|
Prescription Drug (RX)
|
Low Density Polyethylene Plastic Vial with Rubber stopper x 20mL (Box of 20's)
|
-
|
Euro-med Laboratories Phil. Inc.
|
Philippines
|
|
|
|
-
|
20 March 2020
|
25 May 2025
|
| View |
|
DR-XY19791-B
|
Chloramphenicol (as palmitate)
|
Sustachlor
|
125 mg/5 mL
|
Suspension
|
Prescription Drug (Rx)
|
60 mL Amber Bottle
|
Antibacterial (Amphenicol)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Metz Pharmaceuticals, Inc.
|
N/A
|
N/A
|
Renewal
|
25 August 2022
|
10 October 2027
|
| View |
|
DR-XY19793
|
Paracetamol
|
Medgenol
|
100mg/ mL
|
Syrup (Oral Drops)
|
Over-The-Counter (OTC)
|
USP Type III borosilicate amber bottle with white metal cap x 15 mL (Box of 1's)
|
Analgesic / Antipyretic
|
Fortis Medi Pharmaceutical, Inc.
|
Philippines
|
|
|
MG Prime Pharmaceutical, Inc.
|
Automatic Renewal
|
14 October 2021
|
15 September 2026
|
| View |
|
DR-XY19811-B
|
Allopurinol
|
Purispec
|
300 mg
|
Tablet
|
Prescription Drug (RX)
|
Aluminum Foil Strip x 10's (Box of 100's)
|
Antigout
|
Lloyd Laboratories, Inc.
|
Philippines
|
Pharmaspec N.A., Inc.
|
|
|
Automatic Renewal
|
08 July 2022
|
01 August 2027
|
| View |
|
DR-XY19821
|
Carbocisteine
|
Cemetol
|
50mg/mL
|
Syrup (Oral Drops)
|
Over-The-Counter (OTC)
|
GLASS BOTTLE 15ML
|
Mucolytics
|
Drugmaker's Laboratories Inc.
|
Philippines
|
|
|
|
Automatic Renewal
|
19 January 2022
|
11 April 2027
|
| View |
|
DR-XY19832
|
Vitamin B1 + B6 + B12
|
Vibee
|
100mg/ 200mg/ 200mcg
|
Film-Coated Tablet
|
Over-The-Counter (OTC)
|
Aluminum Foil Strip
|
Vitamin
|
Biolab Co., Ltd.
|
Thailand
|
|
The Cathay YSS Distributors, Co., Inc
|
The Cathay YSS Distributors, Co., Inc
|
Automatic Renewal
|
05 January 2022
|
17 April 2027
|
| View |
|
DR-XY19833
|
Salbutamol (as Sulfate)
|
None
|
2mg/ 5mL
|
Syrup
|
Prescription Drug (Rx)
|
Amber bottle x 60 mL
|
Selective Beta-2-Adrenoreceptor Agonist
|
FORTIS MEDI PHARMACEUTICAL, INC.
|
Philippines
|
none
|
none
|
none
|
Renewal
|
28 April 2022
|
06 July 2027
|
| View |
|
DR-XY1986
|
Nitroglycerin
|
Transderm-Nitro 5
|
5 mg/24 Hr
|
Trandermal Patch
|
Prescription Drug (RX)
|
Individual sachet x 1 patch (Box of 30's)
|
-
|
Novartis Pharma Stein AG
|
Switzerland
|
|
Novartis Healthcare Philippines, Inc.'
|
Novartis Healthcare Philippines, Inc.'
|
-
|
06 January 2021
|
13 January 2025
|
| View |
|
DR-XY19867
|
Meclizine Hydrochloride
|
Bonamine
|
12.5 mg
|
Chewable Tablet
|
Over-the-Counter (OTC)
|
Blister pack x 30's
|
Anti-emetic
|
Interphil Laboratories, Inc.
|
Philippines
|
Taisho Pharmaceuticals (Philippines), Inc.
|
N/A
|
N/A
|
Renewal
|
29 March 2024
|
21 October 2029
|